Citation Impact
Citing Papers
A New Triggering Receptor Expressed on Myeloid Cells (Trem) Family Member, Trem-Like 4, Binds to Dead Cells and Is a DNAX Activation Protein 12-Linked Marker for Subsets of Mouse Macrophages and Dendritic Cells
2009 StandoutNobel
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants
2016 Standout
TREM2 in CNS homeostasis and neurodegenerative disease
2015
Treml4, an Ig Superfamily Member, Mediates Presentation of Several Antigens to T Cells In Vivo, Including Protective Immunity to HER2 Protein
2011 StandoutNobel
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Thiazolidinediones
2004 Standout
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone
2003
Gastric Bypass Surgery Improves Metabolic and Hepatic Abnormalities Associated With Nonalcoholic Fatty Liver Disease
2006
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
2018
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
2004
Liver fibrosis
2005 Standout
The TREM receptor family and signal integration
2006
Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts
2000
Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
2006
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
Cushing's syndrome
2015 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
2005 Standout
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017 Standout
Interim results of a pilot study demonstrating the early effects of the PPAR-γ ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis
2003
Benefits of lifestyle modification in NAFLD
2007
IgG4-Related Hypophysitis: A New Addition to the Hypophysitis Spectrum
2011
Value of FDG PET Imaging in the Management of Patients With Thyroid, Neuroendocrine, and Neural Crest Tumors
2004
One-Year Intense Nutritional Counseling Results in Histological Improvement in Patients with Nonalcoholic Steatohepatitis: A Pilot Study
2005
Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
2008
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
2009 Standout
AGA technical review on nonalcoholic fatty liver disease
2002
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga‐DOTATATE (DOTA‐D Phe1,Tyr3‐octreotate) and 18F‐FDG
2008
The metabolic syndrome
2005 Standout
A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
2006
Non-alcoholic fatty liver disease
2021 Standout
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis
2001
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
2005 Standout
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
2009
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
The Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease
2012
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome
2007
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Liver Pathology in Morbidly Obese Patients Undergoing Roux-en-Y Gastric Bypass Surgery
2002
Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS
2004
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Developmental Regulation of TREM2 and DAP12 Expression in the Murine CNS: Implications for Nasu-Hakola Disease
2008
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Are there Predictive Factors of Severe Liver Fibrosis in Morbidly Obese Patients with Non-alcoholic Steatohepatitis?
2001
The human uncoupling protein‐1 gene (UCP1): present status and perspectives in obesity research
2000
Association of Cardiorespiratory Fitness, Body Mass Index, and Waist Circumference to Nonalcoholic Fatty Liver Disease
2006
Microglia Promote Learning-Dependent Synapse Formation through Brain-Derived Neurotrophic Factor
2013 Standout
Neuroblastoma
2007 Standout
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
IgG4-related disease
2014 Standout
The Role of [18F]Fluorodeoxyglucose Positron Emission Tomography and [111In]-Diethylenetriaminepentaacetate-d -Phe-Pentetreotide Scintigraphy in the Localization of Ectopic Adrenocorticotropin-Secreting Tumors Causing Cushing’s Syndrome
2004
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Nonalcoholic fatty liver disease
2005 Standout
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology
2015
Cushing's syndrome
2006 Standout
Proposal for a histological scoring and grading system for non‐alcoholic fatty liver disease
2005
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
2010
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Laparoscopic Adjustable Gastric Banding for the Treatment of Morbid (Grade 3) Obesity and its Metabolic Complications: A Three-Year Study
2002
AGA technical review on obesity
2002
Hepatocellular Carcinoma
2011 Standout
Diagnosis of fatty liver disease
2003
Nasu–Hakola Disease (Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy—PLOSL): A Dementia Associated with Bone Cystic Lesions. From Clinical to Genetic and Molecular Aspects
2004
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
2003
Roux‐en‐Y Gastric Bypass Improves Liver Histology in Patients with Non‐Alcoholic Fatty Liver Disease
2005
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Natural killer cells, viruses and cancer
2001
Bariatric Surgery and Cardiovascular Risk Factors
2011
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
2013
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
2003 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial
2004
The genetic causes of basal ganglia calcification, dementia, and bone cysts
2005
Pharmacological and surgical treatment of obesity.
2004
Improved Nonalcoholic Steatohepatitis After 48 Weeks of Treatment With the Ppar–γ Ligand Rosiglitazone
2003
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
2000
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Brown Adipose Tissue: Function and Physiological Significance
2004 Standout
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Meta-Analysis: Surgical Treatment of Obesity
2005 Standout
Bronchiolitis Obliterans Organizing Pneumonia
1994
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Engagement of NKG2D by Cognate Ligand or Antibody Alone Is Insufficient to Mediate Costimulation of Human and Mouse CD8+ T Cells
2005 StandoutNobel
Nonalcoholic Fatty Liver Disease
2015 Standout
Place Cells and Place Recognition Maintained by Direct Entorhinal-Hippocampal Circuitry
2002 StandoutScienceNobel
TREM2 sustains microglial expansion during aging and response to demyelination
2015
Works of A Thiry being referenced
Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation
1998
Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty
1998
Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67
2002
Extensive Inflammatory Pseudotumor of the Pituitary
2001
Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia.
1997